Target intelligence / Profile preview

RN7SK pseudogene 229 (RN7SKP229)

Target
RN7SKP229
Molecular classification
Other (Pseudogene)
01

Overview

RN7SK pseudogene 229 (RN7SKP229) is a human genomic locus classified as a noncoding RNA pseudogene, specifically a member of the large group of RN7SK-related pseudogenes. While the *functional* RN7SK gene encodes 7SK small nuclear RNA, an essential noncoding RNA component involved in the regulation of RNA Polymerase II transcription elongation, RN7SKP229 itself is not known to be transcribed or translated, and is assumed to lack biological activity. As with most pseudogenes, RN7SKP229 likely arose from duplication or retrotransposition events, and does not function as a therapeutic target[6][3]. Key context: - The *functional* RN7SK gene and its RNA product play a crucial role in transcription regulation, mediating control of P-TEFb and affecting processes including the cell cycle and disease, but this is distinct from pseudogenes such as RN7SKP229[1][2][5][7]. - Pseudogenes often share sequence similarity to their parent genes but lack protein-coding ability or function due to disabling mutations[3][6]. Summary of appropriateness: RN7SKP229 should not be used as a canonical therapeutic target in drug discovery or molecular biology. Any references to targeting "RN7SKP229" would be incorrect; the functional/non-pseudogene counterpart ("RN7SK small nuclear RNA") is the relevant molecule for functional studies.

Other names
RNA, 7SK small nuclear pseudogene 229

Beyond the preview

Go deeper on RN7SK pseudogene 229 (RN7SKP229).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 229 (RN7SKP229).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call